Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Autoimmune Disorders

  Free Subscription


Articles published in Diabetes

Retrieve available abstracts of 89 articles:
HTML format



Single Articles


    December 2022
  1. PETSIOU A, Vartholomatos G, Tsatsoulis A, Papadopoulos GK, et al
    Comment on Liu et al. Immune and Metabolic Effects of Antigen-Specific Immunotherapy Using Multiple beta-Cell Peptides in Type 1 Diabetes. Diabetes 2022;71:722-732.
    Diabetes. 2022;71:e20-e21.
    PubMed    


  2. MISRA S, DiMeglio LA
    COVID-19 and Incident Type 1 Diabetes: Deciphering the Associations.
    Diabetes. 2022;71:2480-2482.
    PubMed    


  3. PIETROPAOLO M, Hotez P, Giannoukakis N
    Response to Comment on Pietropaolo et al. Incidence of an Insulin-Requiring Hyperglycemic Syndrome in SARS-CoV-2- Infected Young Individuals: Is It Type 1 Diabetes? Diabetes 2022;71:2656-2663.
    Diabetes. 2022;71:e19.
    PubMed    


  4. HSU CK, Lai CC
    Comment on Pietropaolo et al. Incidence of an Insulin-Requiring Hyperglycemic Syndrome in SARS-CoV-2-Infected Young Individuals: Is It Type 1 Diabetes? Diabetes 2022;71:2656-2663.
    Diabetes. 2022;71:e18.
    PubMed    


  5. SYREENI A, Dahlstrom EH, Hagg-Holmberg S, Forsblom C, et al
    Haptoglobin Genotype Does Not Confer a Risk of Stroke in Type 1 Diabetes.
    Diabetes. 2022;71:2728-2738.
    PubMed     Abstract available


  6. GOU W, Hua W, Swaby L, Cui W, et al
    Stem Cell Therapy Improves Human Islet Graft Survival in Mice via Regulation of Macrophages.
    Diabetes. 2022;71:2642-2655.
    PubMed     Abstract available


    November 2022
  7. DERR AG, Arowosegbe A, Satish B, Redick SD, et al
    An Early Islet Transcriptional Signature is Associated with Local Inflammation in Autoimmune Diabetes.
    Diabetes. 2022 Nov 8. pii: 147854. doi: 10.2337/db22-0521.
    PubMed     Abstract available


  8. NG XW, Chung YH, Asadi F, Kong C, et al
    RhoA as a Signaling Hub Controlling Glucagon Secretion From Pancreatic alpha-Cells.
    Diabetes. 2022;71:2384-2394.
    PubMed     Abstract available


    October 2022
  9. CORKEY BE, Kilpatrick LE, Evans-Molina C
    Hypothesis: Induction of Autoimmunity in Type 1 Diabetes-A Lipid Focus.
    Diabetes. 2022;71:2067-2074.
    PubMed     Abstract available


    September 2022
  10. KWON BC, Achenbach P, Anand V, Frohnert BI, et al
    Islet Autoantibody Levels Differentiate Progression Trajectories in Individuals with Presymptomatic Type 1 Diabetes.
    Diabetes. 2022 Sep 16. pii: 147551. doi: 10.2337/db22-0360.
    PubMed     Abstract available


  11. SOOKAROMDEE P, Wiwanitkit V
    Comment on D'Addio et al. Immunogenicity and Safety of SARS-CoV-2 mRNA Vaccines in a Cohort of Patients With Type 1 Diabetes. Diabetes 2022;71:1800-1806.
    Diabetes. 2022;71:e13.
    PubMed    


  12. D'ADDIO F, Fiorina P
    Response to Comment on D'Addio et al. Immunogenicity and Safety of SARS-CoV-2 mRNA Vaccines in a Cohort of Patients With Type 1 Diabetes. Diabetes 2022;71:1800-1806.
    Diabetes. 2022;71:e14.
    PubMed    


    August 2022
  13. CRAWFORD SA, Wiles TA, Wenzlau JM, Powell RL, et al
    Cathepsin D Drives the Formation of Hybrid Insulin Peptides Relevant to the Pathogenesis of Type 1 Diabetes.
    Diabetes. 2022 Aug 30. pii: 147526. doi: 10.2337/db22-0303.
    PubMed     Abstract available


  14. MALLONE R, Halliez C, Rui J, Herold KC, et al
    The beta-Cell in Type 1 Diabetes Pathogenesis: A Victim of Circumstances or an Instigator of Tragic Events?
    Diabetes. 2022;71:1603-1610.
    PubMed     Abstract available


    June 2022
  15. CORVILLO F, Abel BS, Lopez-Lera A, Ceccarini G, et al
    Characterization and Clinical Association of Autoantibodies Against Perilipin 1 in Patients with Acquired Generalized Lipodystrophy.
    Diabetes. 2022 Jun 30. pii: 147153. doi: 10.2337/db21-1086.
    PubMed     Abstract available


  16. CHEN M, Hu R, Cavinato C, Zhuang ZW, et al
    Fibronectin-integrin alpha5 signaling in vascular complications of type 1 diabetes.
    Diabetes. 2022 Jun 30. pii: 147154. doi: 10.2337/db21-0958.
    PubMed     Abstract available


  17. ITO Y, Sun R, Yagimuma H, Taki K, et al
    Protein Tyrosine Phosphatase 1B Deficiency Improves Glucose Homeostasis in Insulin-Dependent Diabetes Mellitus Treated with Leptin.
    Diabetes. 2022 Jun 24. pii: 147141. doi: 10.2337/db21-0953.
    PubMed     Abstract available


  18. MEI-LING Y, Sean E C, Renelle G, TuKiet T L, et al
    Carbonyl Post-Translational Modification Associated with Early Onset Type 1 Diabetes Autoimmunity.
    Diabetes. 2022 Jun 22. pii: 147120. doi: 10.2337/db21-0989.
    PubMed     Abstract available


  19. CARRY PM, Waugh K, Vanderlinden LA, Johnson RK, et al
    Changes in the Co-Expression of Innate Immunity Genes During Persistent Islet Autoimmunity are Associated with Progression of Islet Autoimmunity: The Diabetes Autoimmunity Study in the Young (DAISY).
    Diabetes. 2022 Jun 20. pii: 147107. doi: 10.2337/db21-1111.
    PubMed     Abstract available


  20. LEUNG SS, Borg DJ, McCarthy DA, Boursalian TE, et al
    Soluble RAGE Prevents Type 1 Diabetes Expanding Functional Regulatory T Cells.
    Diabetes. 2022 Jun 17. pii: 147090. doi: 10.2337/db22-0177.
    PubMed     Abstract available


  21. MACDONALD MJ, Ansari IH, Riedemann AS, Stoker SW, et al
    A Novel Intron-Encoded Neuropilin-1 Isoform in Pancreatic Islets Associated With Very Young Age of Onset of Type 1 Diabetes.
    Diabetes. 2022 Jun 17. pii: 147085. doi: 10.2337/db21-1070.
    PubMed     Abstract available


  22. MANDEL-BREHM C, Vazquez SE, Liverman C, Cheng M, et al
    Autoantibodies to Perilipin-1 Define a Subset of Acquired Generalized Lipodystrophy.
    Diabetes. 2022 Jun 16. pii: 147096. doi: 10.2337/db21-1172.
    PubMed     Abstract available


    May 2022
  23. LIN Y, Perovanovic J, Kong Y, Igyarto BZ, et al
    Antibody-Mediated Targeting of a Hybrid-Insulin-Peptide Towards Neonatal Thymic Langerin+ Cells Enhances T Cell Central Tolerance and Delays Autoimmune Diabetes.
    Diabetes. 2022 May 27. pii: 147050. doi: 10.2337/db21-1069.
    PubMed     Abstract available


  24. BAKER NL, Hammad SM, Hunt KJ, Semler A, et al
    Plasma ApoM levels and Progression to Kidney Dysfunction in Type 1 Diabetics.
    Diabetes. 2022 May 12. pii: 146945. doi: 10.2337/db21-0920.
    PubMed     Abstract available


  25. D'ADDIO F, Sabiu G, Usuelli V, Assi E, et al
    Immunogenicity and safety of SARS-CoV-2 mRNA vaccines in a cohort of patients with type 1 diabetes.
    Diabetes. 2022 May 12. pii: 146944. doi: 10.2337/db22-0053.
    PubMed     Abstract available


  26. CARR ALJ, Inshaw JRJ, Flaxman CS, Leete P, et al
    Circulating C-Peptide Levels in Living Children and Young People and Pancreatic Beta Cell Loss in Pancreas Donors Across Type 1 Diabetes Disease Duration.
    Diabetes. 2022 May 2. pii: 146866. doi: 10.2337/db22-0097.
    PubMed     Abstract available


  27. YIP L, Alkhataybeh R, Taylor C, Fuhlbrigge R, et al
    Identification of Novel Disease-Relevant Genes and Pathways in the Pathogenesis of Type 1 Diabetes: A Potential Defect in Pancreatic Iron Homeostasis.
    Diabetes. 2022 May 2. pii: 146861. doi: 10.2337/db21-0948.
    PubMed     Abstract available


  28. JING Y, Kong Y, McGinty J, Blahnik-Fagan G, et al
    T-Cell Receptor/HLA Humanized Mice Reveal Reduced Tolerance and Increased Immunogenicity of Posttranslationally Modified GAD65 Epitope.
    Diabetes. 2022;71:1012-1022.
    PubMed     Abstract available


    April 2022
  29. SIMS EK, Besser REJ, Dayan C, Geno Rasmussen C, et al
    Screening for Type 1 Diabetes in the General Population: A Status Report and Perspective.
    Diabetes. 2022;71:610-623.
    PubMed     Abstract available


    March 2022
  30. PIETROPAOLO M, Hotez P, Giannoukakis N
    Incidence of an Insulin-Requiring Hyperglycemic Syndrome in SARS CoV-2-Infected Young Individuals: Is it Type 1 Diabetes?
    Diabetes. 2022 Mar 16. pii: 144830. doi: 10.2337/db21-0831.
    PubMed     Abstract available


  31. DI PAOLA R, Marucci A, Trischitta V
    The Need to Increase Clinical Skills and Change the Genetic Testing Strategy for Monogenic Diabetes.
    Diabetes. 2022;71:379-380.
    PubMed    


    January 2022
  32. LIU YF, Powrie J, Arif S, Yang JHM, et al
    Immune and Metabolic Effects of Antigen-Specific Immunotherapy Using Multiple beta-Cell Peptides in Type 1 Diabetes.
    Diabetes. 2022 Jan 24. pii: 140961. doi: 10.2337/db21-0728.
    PubMed     Abstract available


  33. BROOKS-WORRELL B, Hampe CS, Hattery EG, Palomino B, et al
    Islet Autoimmunity is Highly Prevalent and Associated With Diminished beta-Cell Function in Patients With Type 2 Diabetes in the Grade Study.
    Diabetes. 2022 Jan 21. pii: 140947. doi: 10.2337/db21-0590.
    PubMed     Abstract available


  34. ELVIRA B, Vandenbempt V, Bauza-Martinez J, Crutzen R, et al
    PTPN2 Regulates the Interferon Signaling and Endoplasmic Reticulum Stress Response in Pancreatic beta-Cells in Autoimmune Diabetes.
    Diabetes. 2022 Jan 14. pii: 139308. doi: 10.2337/db21-0443.
    PubMed     Abstract available


  35. LOCKER KCS, Kachapati K, Wu Y, Bednar KJ, et al
    Endosomal Sequestration of TLR4 Antibody Induces Myeloid-Derived Suppressor Cells and Reverses Acute Type 1 Diabetes.
    Diabetes. 2022 Jan 14. pii: 139245. doi: 10.2337/db21-0426.
    PubMed     Abstract available


  36. CHEN X, Li Y, Yuan X, Yuan W, et al
    Methazolamide Attenuates the Development of Diabetic Cardiomyopathy by Promoting beta-Catenin Degradation in Type 1 Diabetic Mice.
    Diabetes. 2022 Jan 14. pii: 139251. doi: 10.2337/db21-0506.
    PubMed     Abstract available


  37. JAMISON BL, DiLisio JE, Beard KS, Neef T, et al
    Tolerogenic Delivery of a Hybrid Insulin Peptide Markedly Prolongs Islet Graft Survival in the Non-Obese Diabetic (NOD) Mouse.
    Diabetes. 2022 Jan 7. pii: 139243. doi: 10.2337/db20-1170.
    PubMed     Abstract available


  38. BEDIAGA NG, Garnham AL, Naselli G, Bandala-Sanchez E, et al
    Cytotoxicity-related gene expression and chromatin accessibility define a subset of CD4+ T cells that mark progression to type 1 diabetes.
    Diabetes. 2022 Jan 7. pii: 139244. doi: 10.2337/db21-0612.
    PubMed     Abstract available


    December 2021
  39. BOEDER SC, Gregory JM, Giovannetti ER, Pettus JH, et al
    SGLT2 Inhibition Increases Fasting Glucagon but Does Not Restore the Counterregulatory Hormone Response to Hypoglycemia in Participants with Type 1 Diabetes.
    Diabetes. 2021 Dec 2. pii: db21-0769. doi: 10.2337/db21-0769.
    PubMed     Abstract available


  40. PANZER JK, Caicedo A
    Targeting the Pancreatic alpha-Cell to Prevent Hypoglycemia in Type 1 Diabetes.
    Diabetes. 2021;70:2721-2732.
    PubMed     Abstract available


    November 2021
  41. SMITH MJ, Pastor L, Newman JRB, Concannon P, et al
    Genetic Control of Splicing at SIRPG Modulates Risk of Type 1 Diabetes.
    Diabetes. 2021 Nov 19. pii: db21-0194. doi: 10.2337/db21-0194.
    PubMed     Abstract available


  42. CHARLES MA, Leslie RD
    Diabetes: Concepts of beta-Cell Organ Dysfunction and Failure Would Lead to Earlier Diagnoses and Prevention.
    Diabetes. 2021;70:2444-2456.
    PubMed     Abstract available


  43. SHARMA RB, Landa-Galvan HV, Alonso LC
    Living Dangerously: Protective and Harmful ER Stress Responses in Pancreatic beta-Cells.
    Diabetes. 2021;70:2431-2443.
    PubMed     Abstract available


    October 2021
  44. VECCHIONE A, Jofra T, Gerosa J, Shankwitz K, et al
    Reduced Follicular Regulatory T Cells in Spleen and Pancreatic Lymph Nodes of Patients With Type 1 Diabetes.
    Diabetes. 2021 Oct 7. pii: db21-0091. doi: 10.2337/db21-0091.
    PubMed     Abstract available


  45. RUSS HA, Davidson HW
    Found in Translation: Novel Insights Into Type 1 Diabetes and beta-Cell Biology.
    Diabetes. 2021;70:2185-2186.
    PubMed    


  46. THOMAIDOU S, Slieker RC, van der Slik AR, Boom J, et al
    Long RNA Sequencing and Ribosome Profiling of Inflamed beta-Cells Reveal an Extensive Translatome Landscape.
    Diabetes. 2021;70:2299-2312.
    PubMed     Abstract available


    September 2021
  47. AZOURY ME, Samassa F, Buitinga M, Nigi L, et al
    CD8+ T cells variably recognize native versus citrullinated GRP78 epitopes in type 1 diabetes.
    Diabetes. 2021 Sep 24. pii: db21-0259. doi: 10.2337/db21-0259.
    PubMed     Abstract available


  48. OH E, McCown EM, Ahn M, Garcia PA, et al
    Syntaxin 4 enrichment in beta-cells prevents conversion to autoimmune diabetes in non-obese diabetic (NOD) mice.
    Diabetes. 2021 Sep 23. pii: db21-0170. doi: 10.2337/db21-0170.
    PubMed     Abstract available


  49. SIMS EK, Cuthbertson D, Herold KC, Sosenko JM, et al
    The Deterrence of Rapid Metabolic Decline within 3 Months after Teplizumab Treatment in Individuals at High Risk for Type 1 Diabetes.
    Diabetes. 2021 Sep 22. pii: db21-0519. doi: 10.2337/db21-0519.
    PubMed     Abstract available


  50. SRIVASTAVA N, Hu H, Vomund AN, Peterson OJ, et al
    Chromogranin A Deficiency Confers Protection from Autoimmune Diabetes Via Multiple Mechanisms.
    Diabetes. 2021 Sep 8. pii: db21-0513. doi: 10.2337/db21-0513.
    PubMed     Abstract available


  51. STONE VM, Butrym M, Hankaniemi MM, Sioofy-Khojine AB, et al
    Coxsackievirus B Vaccines Prevent Infection-Accelerated Diabetes in NOD Mice and Have No Disease-Inducing Effect.
    Diabetes. 2021 Sep 8. pii: db21-0193. doi: 10.2337/db21-0193.
    PubMed     Abstract available


    August 2021
  52. EIZIRIK DL, Szymczak F, Alvelos MI, Martin F, et al
    From Pancreatic beta-Cell Gene Networks to Novel Therapies for Type 1 Diabetes.
    Diabetes. 2021 Aug 20. pii: dbi20-0046. doi: 10.2337/dbi20-0046.
    PubMed     Abstract available


  53. PAGNI PP, Chaplin J, Wijaranakula M, Wesley JD, et al
    Multicomponent Plasmid Protects Mice From Spontaneous Autoimmune Diabetes.
    Diabetes. 2021 Aug 13. pii: db21-0327. doi: 10.2337/db21-0327.
    PubMed     Abstract available


  54. PAGNI PP, Chaplin J, Wijaranakula M, Wesley JD, et al
    Multicomponent Plasmid Protects Mice From Spontaneous Autoimmune Diabetes.
    Diabetes. 2021 Aug 13. pii: 139085. doi: 10.2337/db21-0327.
    PubMed     Abstract available


  55. YANG D, Patel S, Szlachcic WJ, Chmielowiec J, et al
    Pancreatic differentiation of stem cells reveals pathogenesis of a syndrome of Ketosis-Prone Diabetes.
    Diabetes. 2021 Aug 3. pii: db20-1293. doi: 10.2337/db20-1293.
    PubMed     Abstract available


    July 2021
  56. DAHLSTROM EH, Saksi J, Forsblom C, Uglebjerg N, et al
    The low-expression variant of FABP4 is associated with cardiovascular disease in type 1 diabetes.
    Diabetes. 2021 Jul 9. pii: db21-0056. doi: 10.2337/db21-0056.
    PubMed     Abstract available


  57. WANG Y, Niu A, Pan Y, Cao S, et al
    Profile of podocyte translatome during development of type 2 and type 1 diabetic nephropathy using podocyte-specific TRAP mRNA RNA-seq.
    Diabetes. 2021 Jul 7. pii: db21-0110. doi: 10.2337/db21-0110.
    PubMed     Abstract available


    June 2021
  58. LERNMARK A
    Etiology of Autoimmune Islet Disease: Timing Is Everything.
    Diabetes. 2021 Jun 21. pii: dbi18-0034. doi: 10.2337/dbi18-0034.
    PubMed     Abstract available


  59. DASAN MC, Sandireddy R, Bogireddy H, Tee N, et al
    Cardiac Tissue Factor Regulates Inflammation, Hypertrophy and Heart Failure in Mouse Model of Type 1 Diabetes.
    Diabetes. 2021 Jun 21. pii: db20-0719. doi: 10.2337/db20-0719.
    PubMed     Abstract available


  60. NIMKULRAT SD, Bernstein MN, Ni Z, Brown J, et al
    The Anna Karenina Model of beta-Cell Maturation in Development and Their Dedifferentiation in Type 1 and Type 2 Diabetes.
    Diabetes. 2021 Jun 15. pii: db21-0211. doi: 10.2337/db21-0211.
    PubMed     Abstract available


    May 2021
  61. GALINDO-ALBARRAN A, Castan S, Santamaria JC, Joffre OP, et al
    The repertoire of newly developing regulatory T cells in the type I diabetes-prone NOD mouse is very diverse.
    Diabetes. 2021 May 25. pii: db20-1072. doi: 10.2337/db20-1072.
    PubMed     Abstract available


  62. HILLER H, Beachy DE, Lebowitz JJ, Engler S, et al
    Monogenic Diabetes and Integrated Stress Response Genes Display Altered Gene Expression in Type 1 Diabetes.
    Diabetes. 2021 May 25. pii: db21-0070. doi: 10.2337/db21-0070.
    PubMed     Abstract available


  63. JAHOOR F, Hsu JW, Mehta PB, Keene KR, et al
    Metabolomic profiling of patients with A-beta+ Ketosis-Prone Diabetes during diabetic ketoacidosis.
    Diabetes. 2021 May 21. pii: db21-0066. doi: 10.2337/db21-0066.
    PubMed     Abstract available


  64. MALLONE R, You S
    The SAgA of Antigen-Specific Immunotherapy for Type 1 Diabetes.
    Diabetes. 2021 May 20. pii: dbi21-0011. doi: 10.2337/dbi21-0011.
    PubMed    


  65. BETTINI M, Bettini ML
    Function, Failure, and the Future Potential of Tregs in Type 1 Diabetes.
    Diabetes. 2021 May 20. pii: dbi18-0058. doi: 10.2337/dbi18-0058.
    PubMed     Abstract available


  66. BRITTEN-JONES AC, Kamel JT, Roberts LJ, Braat S, et al
    Investigating the neuroPRotective effect of Oral Omega-3 Fatty acid Supplementation in type 1 diabetes (nPROOFS1): a randomised, placebo-controlled trial.
    Diabetes. 2021 May 5. pii: db21-0136. doi: 10.2337/db21-0136.
    PubMed     Abstract available


  67. RODRIGUEZ-CALVO T, Chen YC, Verchere CB, Haataja L, et al
    Altered beta-Cell Prohormone Processing and Secretion in Type 1 Diabetes.
    Diabetes. 2021 May 4. pii: dbi20-0034. doi: 10.2337/dbi20-0034.
    PubMed     Abstract available


  68. GREENBAUM CJ
    A Key to T1D Prevention: Screening and Monitoring Relatives as Part of Clinical Care.
    Diabetes. 2021;70:1029-1037.
    PubMed     Abstract available


    April 2021
  69. CARRY P, Vanderlinden LA, Johnson RK, Buckner T, et al
    Phospholipid Levels at Seroconversion are Associated with Resolution of Persistent Islet Autoimmunity: The Diabetes Autoimmunity Study in the Young.
    Diabetes. 2021 Apr 16. pii: db20-1251. doi: 10.2337/db20-1251.
    PubMed     Abstract available


  70. LINSLEY PS, Greenbaum CJ, Nepom GT
    Uncovering Pathways to Personalized Therapies in Type 1 Diabetes.
    Diabetes. 2021;70:831-841.
    PubMed     Abstract available


    March 2021
  71. FORBES JM, McCarthy DA, Kassianos AJ, Baskerville T, et al
    T-Cell Expression and Release of Kidney Injury Molecule-1 in Response to Glucose Variations Initiates Kidney Injury in Early Diabetes.
    Diabetes. 2021 Mar 18. pii: db20-1081. doi: 10.2337/db20-1081.
    PubMed     Abstract available


  72. BAGGER JI, Grondahl M, Lund A, Holst JJ, et al
    Glucagonostatic Potency of GLP-1 in Patients with Type 2 Diabetes, in Patients with Type 1 Diabetes and in Healthy Controls.
    Diabetes. 2021 Mar 15. pii: db20-0998. doi: 10.2337/db20-0998.
    PubMed     Abstract available


    February 2021
  73. HALLER MJ, Jacobsen LM, Posgai AL, Schatz DA, et al
    How Do We Move Type 1 Diabetes Immunotherapies Forward During the Current COVID-19 Pandemic?
    Diabetes. 2021 Feb 25. pii: dbi20-0045. doi: 10.2337/dbi20-0045.
    PubMed     Abstract available


  74. LIN A, Mack JA, Bruggeman B, Jacobsen LM, et al
    Low-dose ATG/GCSF in Established Type 1 Diabetes: A Five-Year Follow-up Report.
    Diabetes. 2021 Feb 25. pii: db20-1103. doi: 10.2337/db20-1103.
    PubMed     Abstract available


  75. HERDER C, Maalmi H, Strassburger K, Zaharia OP, et al
    Differences in Biomarkers of Inflammation Between Novel Subgroups of Recent-Onset Diabetes.
    Diabetes. 2021 Feb 19. pii: db20-1054. doi: 10.2337/db20-1054.
    PubMed     Abstract available


  76. BOLDISON J, Thayer TC, Davies J, Wong FS, et al
    Natural Protection From Type 1 Diabetes in Non Obese Diabetic (Nod) Mice is Characterised by a Unique Pancreatic Islet Phenotype.
    Diabetes. 2021 Feb 2. pii: db20-0945. doi: 10.2337/db20-0945.
    PubMed     Abstract available


  77. GLIEBERMAN AL, Pope BD, Melton DA, Parker KK, et al
    Building Biomimetic Potency Tests for Islet Transplantation.
    Diabetes. 2021;70:347-363.
    PubMed     Abstract available


  78. PETRELLI A, Atkinson MA, Pietropaolo M, Giannoukakis N, et al
    Modulation of Leukocytes of the Innate Arm of the Immune System as a Potential Approach to Prevent the Onset and Progression of Type 1 Diabetes.
    Diabetes. 2021;70:313-322.
    PubMed     Abstract available


    January 2021
  79. ESPES D, Carlsson PO, Selvaraju RK, Rosestedt M, et al
    Longitudinal Assessment of (11)C-5-Hydroxytryptophan Uptake in Pancreas After Debut of Type 1 Diabetes.
    Diabetes. 2021 Jan 21. pii: db20-0776. doi: 10.2337/db20-0776.
    PubMed     Abstract available


  80. MHANNA V, Fourcade G, Barennes P, Quiniou V, et al
    Impaired Activated/Memory Regulatory T Cell Clonal Expansion Instigates Diabetes in NOD Mice.
    Diabetes. 2021 Jan 21. pii: db20-0896. doi: 10.2337/db20-0896.
    PubMed     Abstract available


  81. ROSS JJ, Wasserfall CH, Bacher R, Perry DJ, et al
    Exocrine Pancreatic Enzymes Are a Serological Biomarker for Type 1 Diabetes Staging and Pancreas Size.
    Diabetes. 2021 Jan 13. pii: db20-0995. doi: 10.2337/db20-0995.
    PubMed     Abstract available


  82. HAUKKA J, Sandholm N, Valo E, Forsblom C, et al
    Novel Linkage Peaks Discovered for Diabetic Nephropathy in Individuals With Type 1 Diabetes.
    Diabetes. 2021 Jan 7. pii: db20-0158. doi: 10.2337/db20-0158.
    PubMed     Abstract available


  83. RODRIGUEZ-CALVO T, Krogvold L, Amirian N, Dahl-Jorgensen K, et al
    One in Ten CD8+ Cells in the Pancreas of Living Individuals With Recent Onset Type 1 Diabetes Recognizes the Preproinsulin Epitope PPI15-24.
    Diabetes. 2021 Jan 7. pii: db20-0908. doi: 10.2337/db20-0908.
    PubMed     Abstract available


    December 2020
  84. SNOWHITE I, Pastori R, Sosenko J, Cayetano SM, et al
    Baseline Assessment of Circulating microRNAs Near Diagnosis of Type 1 Diabetes Predicts Future Stimulated Insulin Secretion.
    Diabetes. 2020 Dec 4. pii: db20-0817. doi: 10.2337/db20-0817.
    PubMed     Abstract available


    November 2020
  85. SODRE FMC, Bissenova S, Bruggeman Y, Tilvawala R, et al
    Peptidylarginine Deiminase Inhibition Prevents Diabetes Development in NOD Mice.
    Diabetes. 2020 Nov 17. pii: db20-0421. doi: 10.2337/db20-0421.
    PubMed     Abstract available


  86. FLOYEL T, Meyerovich K, Prause MC, Kaur S, et al
    SKAP2, a Candidate Gene for Type 1 Diabetes, Regulates beta-Cell Apoptosis and Glycaemic Control in Newly Diagnosed Patients.
    Diabetes. 2020 Nov 17. pii: db20-0092. doi: 10.2337/db20-0092.
    PubMed     Abstract available


  87. SHA S, Pearson JA, Peng J, Hu Y, et al
    TLR9-Deficiency in B Cells Promotes Immune Tolerance via IL-10 in a Type 1 Diabetes Mouse Model.
    Diabetes. 2020 Nov 5. pii: db20-0373. doi: 10.2337/db20-0373.
    PubMed     Abstract available


    October 2020
  88. RUSSO F, Citro A, Squeri G, Sanvito F, et al
    InsB9-23 Gene Transfer To Hepatocytes-Based Combined Therapy Abrogates Recurrence of Type-1 Diabetes After Islet Transplantation.
    Diabetes. 2020 Oct 29. pii: db19-1249. doi: 10.2337/db19-1249.
    PubMed     Abstract available


  89. THAYER TC, Davies J, Pearson JA, Hanna SJ, et al
    Differentiating MHC-Dependent and -Independent Mechanisms of Lymph Node Stromal Cell Regulation of Proinsulin-Specific CD8(+) T-Cells in type 1 Diabetes.
    Diabetes. 2020 Oct 29. pii: db19-1050. doi: 10.2337/db19-1050.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Autoimmune Disorders is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: